1.
Sobańska N, Teichman R, Banasiak AP, Kasprowicz J, Pierzchała JR, Hyjek M, Abram K, Banaś P, Bednarz K, Adamus J. Gliflozins and their beneficial hypoglycaemic effect profile and prevention of cardiovascular complications in patients treated for type II diabetes mellitus. Qual Sport [Internet]. 2023 Feb. 18 [cited 2024 Jul. 6];9(2):11-7. Available from: https://apcz.umk.pl/QS/article/view/42030